OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Trichomoniasis


As per available reports about 1 open access articles, 5 conferences, 1 national symposiums are presently dedicated exclusively to Trichomoniasis and about 3 speakers gave presentations on Trichomoniasis.

Trichomoniasis is a common cause of vaginitis. It is a sexually transmitted infection, and is caused by the single-celled protozoan parasite Trichomonas vaginalis producing mechanical stress on host cells and then ingesting cell fragments after cell death. Trichomoniasis is the most common curable STD in young, sexually active women. An estimated 7.4 million new cases occur each year in women and men.

OMICS International 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies  and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.


Many people do not have any symptoms. If you do get symptoms, they usually happen within 5 to 28 days after being infected.

Symptoms in women include
• Discomfort during sex
• Vaginal odour
• Painful urination
• Itching in or near the vagina

Men rarely have symptoms. When they do have symptoms, they may have discharge from the urethra the urge to urinate frequently and often with pain and burning. It is easily passed between sex partners. It is spread through vaginal intercourse, sharing sex toys, and mutual masturbation if fluids from one partner are passed to the genitals of the other.

Prevention of Trichomoniasis:

Male condom use:

Using condoms may reduce the risk of becoming infected with an STI. Condoms must be put on before beginning any sexual contact. Use condoms with a new partner until you are certain he or she does not have an STI. It is important that you use a condom properly to prevent the risk of trich infection.

Female condom use:

Even if you are using a birth control method to prevent pregnancy, you may wish to use female condoms to reduce your risk of getting an STI.

According to the Centers for Disease Control and Prevention (CDC), an estimated 3.7 million people in the United States have trichomoniasis. This disease is more common in women and, because only about 30% of those infected develop symptoms of trichomoniasis, most infected persons do not know that they carry the parasite.1 For pregnant women, Trichomonas infection is often associated with preterm delivery and low body weight in newborns. Genital inflammation is often associated with disease and can facilitate infection by other sexually transmitted pathogens, including HIV. Importantly, trichomoniasis can be cured with a single dose of antibiotics, emphasizing the need for rapid, highly sensitive tests that can detect this parasite and prompt immediate treatment.

The AmpliVue Trichomonas Assay is an easy-to-use, self-contained, handheld disposable molecular diagnostic test with superb clinical accuracy and with procedural steps consistent with those commonly seen in moderately complex laboratories. The assay requires no upfront extraction of DNA and generates an accurate result in approximately 50 minutes. Like other previously FDA-cleared AmpliVue assays, the AmpliVue Trichomonas Assay does not require the customer to invest in either expensive thermocycling equipment, or any other upfront testing costs. It is anticipated that minimal training will be required, as is the case with Quidel's other five in vitro diagnostic assays that use the AmpliVue platform. Using AmpliVue can therefore significantly lower a laboratory's cost to adopt and maintain the assay's unique molecular testing methods.

"Our AmpliVue Trichomoniasis Assay has shown excellent performance with samples from both symptomatic and asymptomatic patients. We believe that our test will play a critical role in quickly diagnosing this disease, creating opportunities for patient treatment and thereby limiting its spread," said Douglas Bryant, president and chief executive officer of Quidel Corporation.

Relevant conferences

  1. 4th HIV/AIDS, STDs, & STIs Conference,                                                    November 30-December 02, 2015 Hilton Atlanta Airport, Atlanta, USA
  2. 4th Immunology Conference, September 28-30, 2015 Houston, Texas, USA
  3. 2nd Infectious Diseases Conference, August 25-27, 2016 Philadelphia, USA
  4. 2nd Influenza Conference, September 12-14, 2016 Berlin, Germany
  5. Infection Prevention and Control Conference, Aug 1-2, 2016 Frankfurt, Germany
  6. 2nd Innate Immunity Conference, July 21-22, 2016 Berlin, Germany
  7. 2nd Parasitology Conference, August 01-03, 2016 Manchester, UK
  8. 2nd Antibodies Conference, July 14-15, 2016 Philadelphia, USA
  9. 2nd Neuroimmunology & Therapeutics Conference,                                        March 31-April 02, 2016 Atlanta, USA
  10.  7th Vaccines & Vaccination Conference, September 28-30, 2015 Dubai, UAE
  11. 9th Vaccines & Vaccination Conference,                                                           November 30-December 02, 2015 San Francisco, USA
  12. 10th Vaccines & Vaccination Conference, June 16-18, 2016 Rome, Italy
  13. 13th Vaccines & Vaccination Conference,                                                         November 10-12, 2016 Melbourne, Australia
  14. 2nd Applied Microbiology Conference,                                                             October 31-November 02, 2016 Istanbul, Turkey
  15. 6th Cell & Stem Cells Research Conference,                                                      February 29-March 02, 2016 Philadelphia, USA
  16.  2nd Antibiotics Conference October 03-05, 2016 London, UK
  17. 5th Cancer Therapy Conference, September 28-30, 2015 Atlanta, Georgia, USA
  18. Beneficial Microbes: Food, Pharma, Aqua & Beverages Industry Conference, September 23-25, 2016 Phoenix, USA
  19. 4th Bacteriology and Infectious Diseases Conference,                                        May 16-18, 2016 San Antonio, USA
  20. Allergy Conference, March 29-30, 2016 Valencia, Spain
  21. United States Conference on AIDS
  22. 2015 National HIV Prevention Conference
  23. The North American Housing and HIV/AIDS Research Summit VIII
  24. World STI & HIV Congress joint with the Australasian HIV & AIDS Conference
  25. 15th European AIDS Conference
  26. 7th International Workshop on HIV Persistence during Therapy
  27. World STI & HIV Congress
  28. 17th Bangkok International Symposium on HIV Medicine
  29. World STI & HIV Congress
  30. 7th International Workshop on HIV Persistence, Reservoirs and Cure
  31. 27th Annual National Conference on Social Work and HIV/AIDS
  32. 21st International AIDS Conference

Relevant Societies

  1. International AIDS Society
  2. American Foundation for Children with AIDS
  3. British Columbia Centre for Excellence in HIV/AIDS
  4. European AIDS Clinical Society
  5.  HIV Medicine Association
  6. The British Association for Sexual Health and HIV
  7. FACE AIDS
  8. Hong Kong AIDS Foundation
  9. Malaysian AIDS Council
  10. WHO‘s HIV/AIDS Department
  11. Southern African HIV Clinicians Society
  12. Australian Federation Aids Organizations
  13. ANTIAIDS Foundation
  14. Apparel Lesotho Alliance to fight AIDS
  15. AIDS Action Committee of Massachusetts
  16. AIDS Foundation Houston

Relevant Companies

  1. AstraZeneca
  2. Astellas
  3. Bayer's Pharma
  4. Cipla
  5. Dr. Reddy’s Laboratories Ltd.
  6. GlaxoSmithKline plc.
  7. Gilead
  8. Merck & Co.
  9. Natco Pharma
  10. Novartis
  11. Novo Nordisk
  12. Pfizer
  13. Roche
  14. Sunpharma
  15. Sanofi
  16. Vaxgen

This page will be updated regularly.

This page was last updated on 09th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising